8VC

Tempero Bio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for the treatment and prevention of substance use disorders. The company aims to address the challenges faced by individuals struggling with addiction, providing transformative solutions that help patients overcome treatment obstacles and support their recovery journey. Through its specialized approach, Tempero Bio is dedicated to improving the lives of those affected by substance use disorders and related conditions.

Latent Labs is making biology programmable to transform health and sustainability for the benefit of all. We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering. Contact us to work with us today.

Sirona Medical, Inc. is a technology company that has developed a cloud-native diagnostic engine tailored for radiologists. Founded in 2018 and headquartered in San Francisco, California, Sirona aims to revolutionize the field of radiology by providing a unified platform that integrates various essential tools, including a universal worklist, viewer, reporter, and AI capabilities. This innovative system simplifies complex workflows, enhances productivity, and allows practitioners to focus on patient care rather than administrative tasks. By streamlining operations and incorporating advanced AI technologies, Sirona empowers radiologists to work more efficiently and effectively, enabling them to deliver better and faster healthcare services.

Seen Health is a healthcare firm focused on empowering older adults to age with dignity within their communities. The company specializes in culturally-informed, technology-enabled healthcare services that combine medical care and social support. Through its Program of All-Inclusive Care for the Elderly (PACE) model, Seen Health aims to provide quality care tailored to the unique needs of older adults, facilitating a holistic approach to health and well-being.

Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.

Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.

Operator of a data-driven healthcare startup intended to transform healthcare in rural communities through exceptional care, bringing better access and quality service to its patients. The company delivers tailored quality care through a team-based model, with resources and support for patients, inside and outside clinics, thereby enabling healthcare professionals to provide the support and care that patients need.

Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.

Latent Labs is making biology programmable to transform health and sustainability for the benefit of all. We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering. Contact us to work with us today.

Cellares Corporation, founded in 2019 and based in South San Francisco, California, focuses on advancing cell therapy for cancer treatment by addressing the significant manufacturing challenges associated with these therapies. The company has developed the Cell Shuttle, an automated and closed end-to-end manufacturing solution designed to enhance the scalability and efficiency of cell therapy production. This innovative system allows for the simultaneous production of multiple patient doses, achieving tenfold scalability compared to traditional methods, while also reducing process failure rates by three times and lowering manufacturing costs by up to 70 percent. Cellares aims to make life-saving cell therapies more affordable and widely accessible to patients in need, thereby accelerating the development and availability of these critical treatments.

Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that connect diagnosis and treatment through a comprehensive ecosystem of devices, software, and services. By empowering patients to monitor their health and manage diseases, Vital Bio aims to enhance the overall healthcare experience. Their approach seeks to reduce disparities in healthcare outcomes and redistribute control to patients while equipping healthcare providers with the tools necessary to achieve better results.

Nest Health is a family healthcare platform that provides a range of medical services aimed at reducing the stress associated with traditional healthcare arrangements. The company specializes in delivering in-home and virtual visits for patients of all ages, including newborns, children, teens, and adults. Their offerings encompass preventive care, sick visits, behavioral health support, nutrition guidance, and chronic disease management. By enabling patients to receive care in the comfort of their homes, Nest Health seeks to enhance accessibility and convenience in healthcare delivery.

Elion operates a digital health software marketplace that connects healthcare builders with a variety of software and service vendors through its online platform. The company provides comprehensive vendor listings, detailed product evaluations, and educational resources, allowing healthcare providers to research, compare, and select technology solutions tailored to improve their operations and enhance patient care. By facilitating informed technology decisions, Elion aims to support both startups and established organizations in delivering better healthcare outcomes.

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed. The company provides an injectable biodegradable hydrogel that allows for the prolonged, localized release of most cancer immunotherapy on the website of surgical tumor resection by focusing the dose at the right place and right time.

Alloy Therapeutics is a biotechnology company founded in 2017 and headquartered in Waltham, Massachusetts. The firm specializes in democratizing access to drug discovery through its innovative platforms and services. Its flagship offering, Alloy-Gx, is a suite of immunocompetent transgenic mice designed for optimal in vivo human antibody discovery. This royalty-free platform allows researchers broad and non-exclusive access to essential drug discovery tools, streamlining the process of antibody project development. By providing these resources, Alloy Therapeutics aims to facilitate advancements in antibody research and ultimately enhance the drug discovery landscape.

KeyCare is a virtual care platform powered by Epic that was created to assist forward-thinking health systems in increasing patient access and quality by enhancing the alternatives available for virtual care.

BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.

Cartography Biosciences is a biotechnology company focused on developing cancer therapies through precision medicine. The company has created a platform-based cell therapy that utilizes single-cell analysis to identify innovative CAR-T targets. This approach allows for the design of cancer immunotherapies tailored to the safest and most effective targets. By combining molecular biology and computational methods, Cartography enables clients to advance their studies in the development of these targeted treatments, aiming to improve outcomes for cancer patients.

Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.

Theia is a pioneering personalized health service designed specifically for mothers, offering both online and offline access to a network of qualified doctors and specialists. The platform provides comprehensive care that spans from preconception through early childhood, ensuring that mothers receive holistic support tailored to their individual needs. By utilizing technology, Theia facilitates remote and in-person consultations, enabling parents to connect with healthcare professionals, including psychologists and pediatric experts, through chats and video calls. Additionally, the platform delivers hyper-personalized content and advice, helping parents navigate each stage of pregnancy and childcare while balancing their professional lives. Theia's commitment to understanding and respecting the unique desires of mothers underpins its mission to offer reliable and compassionate care throughout their journey.

Ritten operates an electronic medical records platform designed specifically for addiction treatment providers to enhance the quality of care for their patients. The platform facilitates personalized, data-informed care by offering customized workflow configurations that support the consistent and compliant delivery of complex treatment. It enables clinicians and administrators to maintain comprehensive patient records that encompass all aspects of a patient's care, including clinical notes, medications, and treatment plans. This approach allows healthcare professionals to provide tailored care while effectively tracking patient progress and needs.

Sirona Medical, Inc. is a technology company that has developed a cloud-native diagnostic engine tailored for radiologists. Founded in 2018 and headquartered in San Francisco, California, Sirona aims to revolutionize the field of radiology by providing a unified platform that integrates various essential tools, including a universal worklist, viewer, reporter, and AI capabilities. This innovative system simplifies complex workflows, enhances productivity, and allows practitioners to focus on patient care rather than administrative tasks. By streamlining operations and incorporating advanced AI technologies, Sirona empowers radiologists to work more efficiently and effectively, enabling them to deliver better and faster healthcare services.

Immunai Inc. is a biotechnology company that specializes in immune profiling through its artificial intelligence-based platform, which combines single-cell genomics and machine learning. Founded in 2018 and headquartered in New York City, with additional offices in San Francisco and Tel Aviv, Immunai aims to map the immune system comprehensively. Its technology allows for high-resolution profiling of immune cells from blood samples, enabling the identification of numerous cell types and their states. This approach generates valuable biological insights that support drug development, particularly in oncology and autoimmune disorders. The company collaborates with academic institutions, biopharmaceutical firms, and biotechnology companies to drive research in areas such as cancer therapy and vaccines.

Better Health is a support and supplies platform designed to improve the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The platform offers expert guidance to help patients select and use the appropriate medical supplies while providing education and support to enhance engagement and adherence to treatment. This approach is endorsed by healthcare payers and providers, leading to better health outcomes, reduced overutilization of services, and improved mental health for users. Better Health operates across 48 states and collaborates with major payers, including Medicare, Medicaid, and several private insurers. The platform boasts a high customer satisfaction rating of 98%, reflecting its effectiveness in modernizing the medical supplies industry and lowering healthcare costs for insurers and patients alike.

Melvi is a health marketplace based in São Paulo, Brazil, that connects patients with clinics for easy access to same-day appointments at affordable prices. Founded in 2021 by Mariana Paixão, Marcela Sobrinho, and Nino Vashakidze, the platform serves as a reliable resource for patients seeking consultations tailored to their needs. It also acts as a partner for clinics by driving a steady flow of new patients, thereby enhancing their occupancy rates. Melvi offers a comprehensive range of healthcare services, including online and in-person consultations across various specialties such as psychiatry, psychology, and nutrition. The platform features a network of qualified doctors and provides options for discounted examinations and online payment, streamlining the healthcare experience for both patients and providers.

Appia Bio is a biotechnology company dedicated to the research and development of allogeneic cell therapies that can be readily available for patients. The company focuses on creating engineered cell therapies for various medical conditions using its innovative ACUA technology platform. This platform utilizes the biology of lymphocyte development along with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to produce CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes derived from hematopoietic stem cells. By maturing and scaling healthy stem cells into these therapies, Appia Bio aims to provide safe and targeted cancer treatments, thereby enhancing accessibility to off-the-shelf cell therapies for physicians and patients alike.

Cellares Corporation, founded in 2019 and based in South San Francisco, California, focuses on advancing cell therapy for cancer treatment by addressing the significant manufacturing challenges associated with these therapies. The company has developed the Cell Shuttle, an automated and closed end-to-end manufacturing solution designed to enhance the scalability and efficiency of cell therapy production. This innovative system allows for the simultaneous production of multiple patient doses, achieving tenfold scalability compared to traditional methods, while also reducing process failure rates by three times and lowering manufacturing costs by up to 70 percent. Cellares aims to make life-saving cell therapies more affordable and widely accessible to patients in need, thereby accelerating the development and availability of these critical treatments.

Alloy Therapeutics is a biotechnology company founded in 2017 and headquartered in Waltham, Massachusetts. The firm specializes in democratizing access to drug discovery through its innovative platforms and services. Its flagship offering, Alloy-Gx, is a suite of immunocompetent transgenic mice designed for optimal in vivo human antibody discovery. This royalty-free platform allows researchers broad and non-exclusive access to essential drug discovery tools, streamlining the process of antibody project development. By providing these resources, Alloy Therapeutics aims to facilitate advancements in antibody research and ultimately enhance the drug discovery landscape.

Better Health is a support and supplies platform designed to improve the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The platform offers expert guidance to help patients select and use the appropriate medical supplies while providing education and support to enhance engagement and adherence to treatment. This approach is endorsed by healthcare payers and providers, leading to better health outcomes, reduced overutilization of services, and improved mental health for users. Better Health operates across 48 states and collaborates with major payers, including Medicare, Medicaid, and several private insurers. The platform boasts a high customer satisfaction rating of 98%, reflecting its effectiveness in modernizing the medical supplies industry and lowering healthcare costs for insurers and patients alike.

BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.

Concerto Biosciences specializes in rebuilding microbial communities to enhance human health and environmental sustainability. The company has developed an ultra-high-throughput platform capable of measuring millions of microbial interactions, enabling the mapping of complex inter-species networks that dictate community behavior. This innovation allows Concerto to create "ensembles," which are specific combinations of microbes that collaboratively promote the recovery of damaged microbial ecosystems. By focusing on these microbial ensembles, Concerto aims to address critical global issues across various sectors, including agriculture, healthcare, and industry. The company's pioneering work positions it as a leader in the development of microbial solutions, fundamentally changing how humanity interacts with microbial life.

Resilience is a technology-driven biomanufacturing company focused on enhancing access to complex medicines, including biologics, vaccines, nucleic acids, and cell and gene therapies. The firm aims to transform the production of medicine by providing a comprehensive range of customized manufacturing capabilities that cater to the diverse needs of biopharmaceuticals throughout all stages of drug development, from pre-clinical to commercial supply. Resilience is committed to creating a sustainable network of advanced manufacturing solutions that ensure rapid, safe, and scalable production of treatments, thereby enabling partners to concentrate on breakthrough discoveries that improve patient outcomes. The company's innovative approach also strengthens biopharmaceutical supply chains, preparing them for future challenges.

Cellares Corporation, founded in 2019 and based in South San Francisco, California, focuses on advancing cell therapy for cancer treatment by addressing the significant manufacturing challenges associated with these therapies. The company has developed the Cell Shuttle, an automated and closed end-to-end manufacturing solution designed to enhance the scalability and efficiency of cell therapy production. This innovative system allows for the simultaneous production of multiple patient doses, achieving tenfold scalability compared to traditional methods, while also reducing process failure rates by three times and lowering manufacturing costs by up to 70 percent. Cellares aims to make life-saving cell therapies more affordable and widely accessible to patients in need, thereby accelerating the development and availability of these critical treatments.

Dren Bio is a biotechnology company that specializes in protein engineering technologies designed to target and deplete pathogenic cells, protein aggregates, and other disease-causing agents. With a focus on hematologic neoplasms, solid cancers, autoimmune disorders, and diseases related to protein aggregation, the company aims to provide innovative solutions for healthcare professionals in their efforts to combat various serious diseases. Operating under a holding company model, Dren Bio develops multiple projects as standalone assets, seeking to create value through its diverse portfolio of biotechnology initiatives.

Sonoma Pharmaceuticals, Inc. is a global healthcare company that develops and produces stabilized hypochlorous acid (HOCl) products for diverse applications, including wound care, dermatology, animal health, eye care, and oral care. Based in Woodstock, Georgia, and incorporated in 1999, the company offers over 100 commercially available products worldwide. Its key offerings include Epicyn, an antimicrobial facial cleanser; Levicyn, a prescription product for managing dermatoses; Celacyn gel for scar management; and SebuDerm for seborrhea relief. Additionally, Sonoma provides Acuicyn for eye care, Microcyn for expedited wound healing, and various products targeting animal health, such as MicrocynAH and MicrocynVS. The company's focus on addressing unmet medical needs in chronic skin conditions significantly contributes to enhancing patient care while aiming to reduce overall healthcare costs. Sonoma Pharmaceuticals was previously known as Oculus Innovative Sciences, Inc. and rebranded in December 2016.

Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of Treg cell therapeutic capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies.

Sirona Medical, Inc. is a technology company that has developed a cloud-native diagnostic engine tailored for radiologists. Founded in 2018 and headquartered in San Francisco, California, Sirona aims to revolutionize the field of radiology by providing a unified platform that integrates various essential tools, including a universal worklist, viewer, reporter, and AI capabilities. This innovative system simplifies complex workflows, enhances productivity, and allows practitioners to focus on patient care rather than administrative tasks. By streamlining operations and incorporating advanced AI technologies, Sirona empowers radiologists to work more efficiently and effectively, enabling them to deliver better and faster healthcare services.

Orca Bio is a clinical-stage cell therapy company focused on providing curative treatments for patients suffering from malignant and autoimmune diseases. The company has developed proprietary technologies aimed at replacing diseased blood and immune systems with healthy cells. Orca Bio specializes in the research and development of innovative cell therapies that enhance the effectiveness of bone marrow transplants, creating a life-saving platform for various medical conditions. With a team of leading experts and technologists, Orca Bio is committed to advancing its pipeline of therapies to improve patient outcomes and transform healthcare practices.

Alloy Therapeutics is a biotechnology company founded in 2017 and headquartered in Waltham, Massachusetts. The firm specializes in democratizing access to drug discovery through its innovative platforms and services. Its flagship offering, Alloy-Gx, is a suite of immunocompetent transgenic mice designed for optimal in vivo human antibody discovery. This royalty-free platform allows researchers broad and non-exclusive access to essential drug discovery tools, streamlining the process of antibody project development. By providing these resources, Alloy Therapeutics aims to facilitate advancements in antibody research and ultimately enhance the drug discovery landscape.

Mindstrong operates a virtual mental health platform designed to enhance mental well-being through the integration of care, data, and technology. The platform addresses personal, societal, and economic challenges related to mental health, utilizing a biomarker panel that assesses brain function based on passive and continuous interaction patterns from human-computer interfaces. This innovative approach allows expert clinicians to deliver evidence-based interventions while offering personalized support and therapy, making mental health care more accessible. Mindstrong has successfully assisted thousands of individuals, including those with serious mental illnesses, in improving their mental health and overall quality of life.

Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.

Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of Treg cell therapeutic capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies.

BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.

Eight Sleep, Inc. is a sleep technology company based in New York, founded in 2014. It specializes in the manufacturing and sale of smart mattresses that feature advanced temperature control, allowing users to cool or heat each side of the bed according to their preferences. The products are designed to enhance comfort and support optimal rest, health, and daily functioning by tracking heart rate and other health metrics. In addition to smart mattresses, Eight Sleep offers a range of accessories, including sleep trackers, pillows, organic sheets, foundations, waterproof protectors, blue wave glasses, and gravity blankets. The company primarily sells its products online and is recognized for its innovation in the sleep industry, having been named one of the Most Innovative Companies in Consumer Electronics by Fast Company in 2018.

ProteinQure Inc. is a biotechnology company based in Toronto, Canada, founded in 2017. It specializes in the development and manufacturing of protein-based therapeutic drugs, focusing on the design of novel exotic peptides for a wide range of therapeutic applications. The company employs advanced technologies such as quantum computing, molecular simulations, and reinforcement learning to facilitate the engineering of novel therapeutics. By utilizing atomic-level simulations and artificial intelligence, ProteinQure aims to create dynamic peptides that effectively target specific disease pathways, potentially outperforming traditional drug delivery systems. The company’s innovative approach seeks to enhance drug discovery and design, offering new possibilities for treating previously untreatable conditions. ProteinQure prides itself on its diverse team, which integrates expertise from experimental and computational biology, machine learning, and software engineering to advance the field of drug development.

Deciduous Therapeutics is a biotechnology company focused on developing innovative immune-modulatory therapies aimed at treating age-related diseases. The company specializes in novel therapeutics that activate the body's natural immune surveillance mechanisms to selectively eliminate senescent cells, which are associated with various age-related health issues. By promoting the clearance of these cells, Deciduous Therapeutics seeks to enhance healthspan and potentially improve the quality of life for individuals experiencing the effects of aging. The company is led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, who has founded multiple biotech ventures.

Hims & Hers is a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals, facilitating access to high-quality medical care for various conditions, including mental health, sexual health, dermatology, and primary care. Founded in 2017, the company initially focused on telehealth services for erectile dysfunction and hair loss but quickly expanded its offerings to include a wider range of health services. Its mission is to eliminate stigmas surrounding health and wellness, making it easier for individuals to seek necessary care. Utilizing a telemedicine approach, Hims & Hers allows customers to receive diagnoses and treatments conveniently and cost-effectively. To support its operations, the company developed its own Electronic Health Record (EHR) system and collaborates with several healthcare operators to provide access to in-person medical visits.

Opencare Inc. operates a healthcare discovery platform that connects patients with healthcare providers in North America, primarily focusing on dental services. Founded in 2012 and based in Toronto, Canada, the company's platform allows users to find and book appointments online with a variety of healthcare professionals, including dentists, chiropractors, massage therapists, physiotherapists, and optometrists. By transforming the dental industry, Opencare aims to provide patients with confidence in receiving high-quality care while also facilitating practice growth for top dentists. The platform streamlines interactions between patients and providers, ensuring a convenient and rewarding experience for all users. Opencare was previously known as HealthKiwi Inc. before rebranding in March 2018.

Notable is an AI-driven platform designed to enhance healthcare operations and improve physician-patient interactions. Deployed at over 10,000 care sites, it automates more than a million repetitive workflows daily, including processes related to registration, scheduling, authorizations, and chart reviews. The platform features a voice-powered application that organizes physician-patient conversations and dictations while securely recommending appropriate billing codes. By streamlining these tasks, Notable reduces manual workload for caregivers and fosters personalized care for patients, ultimately contributing to better financial health for healthcare providers.

100Plus is a rapidly growing remote patient monitoring platform designed to enhance the care of elderly patients with chronic conditions. The platform provides comprehensive services, including patient outreach, device setup, patient engagement, and automatic billing, all integrated with medical devices. By enabling doctors to monitor high-risk seniors remotely, 100Plus helps to prevent costly episodic care and promotes a higher quality of life for patients. When a Medicare patient receives a 100Plus medical device, it is delivered at no cost to them or their healthcare providers, fully configured and ready for immediate use, eliminating the need for smartphones, apps, Bluetooth, or WiFi.

Promise Network Inc. is an organization based in Oakland, California, founded in 2017, that aims to reduce recidivism and enhance community safety by providing alternatives to incarceration. Through its application platform, Promise offers a comprehensive suite of services for arrestees who cannot afford bail, including personalized care plans that incorporate court-mandated conditions and access to essential services such as drug treatment, housing assistance, and job training. The platform facilitates intake and assessment, ongoing support, and supervision, allowing for effective communication and coordination among care teams. By working with county governments, Promise helps manage the jail population and fosters better long-term outcomes for both individuals and communities by promoting rehabilitation over incarceration.

Digital Surgery is a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training.

BlinkRx is a web-based platform that allows users to search for their prescribed medications online and conveniently pick them up from any pharmacy. The platform provides access to branded medications with transparent pricing, offering lower costs to patients across the United States. BlinkRx aims to eliminate barriers to medication access by providing free home delivery, eliminating the need for patients to face unexpected costs or availability issues at pharmacies.

SyntheX, Inc. is a biotechnology company based in San Francisco, California, that specializes in drug discovery focused on therapeutic applications, particularly in oncology. Founded in 2016, SyntheX employs a proprietary screening platform that utilizes synthetic biology to expand the druggable proteome. This platform enables the identification of protein interaction modulators through empirical intracellular selection, allowing for the discovery of compounds that can disrupt specific protein-protein interactions or facilitate functional protein degradation. The company's development portfolio includes stabilized peptide therapeutics, such as STX101 and STX105, aimed at treating cancers that utilize homologous recombination for chemotherapy evasion. SyntheX's approach integrates advanced technologies and engineered circuits to create a robust internal pipeline targeting genetically validated therapeutic mechanisms, while also engaging in external discovery collaborations.

Color is a healthcare technology company that provides a comprehensive platform for managing large-scale health initiatives, including population genomics and COVID-19 testing. The company focuses on delivering equitable and accessible healthcare programs tailored for businesses, schools, and public health departments. By centralizing essential healthcare capabilities, Color addresses logistical challenges and enhances the delivery of preventive care. Its offerings facilitate a range of services, from testing and screening to treatment and referrals, thereby supporting clinical teams in effectively managing public health across diverse populations. Through its innovative model, Color aims to improve health outcomes and create sustainable revenue streams while ensuring that quality healthcare is available to all.

Extract, transport, translate, and share medical information faster for review, coordination, referral, analysis, billing, and auditing.

BlinkRx is a web-based platform that allows users to search for their prescribed medications online and conveniently pick them up from any pharmacy. The platform provides access to branded medications with transparent pricing, offering lower costs to patients across the United States. BlinkRx aims to eliminate barriers to medication access by providing free home delivery, eliminating the need for patients to face unexpected costs or availability issues at pharmacies.